Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	110.47	286.44	136.09
Graham Fair Price	-33.49	6.14	9.23
PEG	894.84	0.42	0.04
Price/Book	27.31	14.36	11.28
Price/Cash Flow	-32.08	112.22	165.22
Prices/Earnings	173.44	-60.70	22.20
Price/Sales	22.74	15.67	12.77
Price/FCF	-32.08	112.22	165.22
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.20	0.39	0.39
Operating Margin	-74.13	0.02	0.07
ROA	-55.27	-0.02	0.04
ROE	0.13	-0.06	-53.44
ROIC	0.03	< 0.005	-69.51
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.06	0.08	-25.92
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.65	-0.74	12.43
EPS QOQ	5.27	-1.45	-72.51
FCF QOQ	-0.15	0.84	456.51
Revenue QOQ	0.07	0.02	-71.68
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	37.33	32.94	-11.75
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.47	0.47	-0.81
Quick Ratio	1.09	1.03	-5.89
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	5.46	5.32	-2.53
Cash	3.01	3.16	4.88
Capex	-0.03	-0.03	-2.76
Free Cash Flow	0.37	0.68	82.69
Revenue	4.82	4.87	1.10
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.19	1.21	1.11
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	6.48	9.31	43.63
Naive Interpretation	Member

06 - Financial Health · Weak

Rating